J
Judith I. Tsui
Researcher at University of Washington
Publications - 119
Citations - 2153
Judith I. Tsui is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Buprenorphine. The author has an hindex of 20, co-authored 85 publications receiving 1540 citations. Previous affiliations of Judith I. Tsui include Boston University & Harborview Medical Center.
Papers
More filters
Journal ArticleDOI
Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial
Jane M. Liebschutz,Denise Crooks,Debra S. Herman,Bradley J. Anderson,Bradley J. Anderson,Judith I. Tsui,Judith I. Tsui,Lidia Z. Meshesha,Shernaz Dossabhoy,Michael D. Stein,Michael D. Stein +10 more
TL;DR: Compared with an inpatient detoxification protocol, initiation of and linkage to buprenorphine treatment is an effective means for engaging medically hospitalized patients who are not seeking addiction treatment and reduces illicit opioid use 6 months after hospitalization.
Journal ArticleDOI
Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System
George N. Ioannou,George N. Ioannou,Lauren A. Beste,Lauren A. Beste,Michael F. Chang,Michael F. Chang,Pamela Green,Elliott Lowy,Judith I. Tsui,Feng Su,Kristin Berry +10 more
TL;DR: High proportions of patients with HCV infections genotypes 1-4 in the Veterans Affairs national health care system achieved SVR12, approaching the results reported in clinical trials, especially in patients with genotype 1 infection.
Journal ArticleDOI
Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
TL;DR: Recent maintenance opioid agonist therapy was associated with a lower incidence of HCV infection in this cohort of young adult injection drug users and maintenance treatment with methadone or buprenorphine for opioid use disorders may be an important strategy to prevent the spread ofHCV infection among young injection drugusers.
Journal ArticleDOI
Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO Study
Jennifer L. Evans,Judith I. Tsui,Judith A. Hahn,Peter J. Davidson,Paula J. Lum,Kimberly Page +5 more
TL;DR: The continued need for public health interventions that address the risk of overdose in this population in order to reduce premature deaths is highlighted, and the mortality rate was 10 times that of the general population.
Journal ArticleDOI
Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine.
Judith I. Tsui,Jim Mayfield,Elizabeth C. Speaker,Sawir Yakup,Richard K. Ries,Harvey Funai,Brian G. Leroux,Joseph O. Merrill +7 more
TL;DR: It is found that patients who concurrently used methamphetamine were less likely to be retained in buprenorphine treatment compared to non-users, and for persons who were retained, however, methamphetamine use decreased over time.